Literature DB >> 9180197

Antibody response to Arcanobacterium haemolyticum infection in humans.

M Nyman1, K R Alugupalli, S Strömberg, A Forsgren.   

Abstract

Arcanobacterium haemolyticum causes pharyngitis, exanthema, and other infections. The evidence of the pathogenicity of A. haemolyticum depends on clinical descriptions of culture-positive patients and a comparison of carrier rates of patients with pharyngitis and healthy, matched controls. In this investigation, the antibody response of the host was studied for the first time, using SDS-PAGE and Western blot analyses. Paired acute and convalescent sera showed development of antibodies to A. haemolyticum in 7 of 8 patients. The antibodies reacted primarily with four distinct cell wall-associated proteins with estimated molecular masses of 80, 60, 50, and 30 kDa. Moreover, the reactivity of convalescent sera from 19 patients was compared with that of sera from 19 controls. Antibodies to A. haemolyticum were found in sera from 16 patients and 6 controls (P < .005); the antibody response of the patients was strong compared with that of the controls. These results indicate that A. haemolyticum infection induces an antibody response in the host.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180197     DOI: 10.1086/516490

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Arcanobacterium haemolyticum: two case reports.

Authors:  M Volante; L Corina; A M Contucci; L Calò; A Artuso
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-06       Impact factor: 2.124

Review 2.  Systemic and deep-seated infections caused by Arcanobacterium haemolyticum.

Authors:  R L Skov; A K Sanden; V H Danchell; K Robertsen; T Ejlertsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 5.103

3.  Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America.

Authors:  Stanford T Shulman; Alan L Bisno; Herbert W Clegg; Michael A Gerber; Edward L Kaplan; Grace Lee; Judith M Martin; Chris Van Beneden
Journal:  Clin Infect Dis       Date:  2012-09-09       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.